Amgen (AMGN)
$307.76
1.38 (0.45%)
AMGN Stock Quote Delayed 30 Minutes
3 Biotech Trades for the Faux Doomsday Scenario
Biotech stocks have been a political football throughout the campaign and even now. Sell risk against the fear and the hope for a profit.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$315.63
Market Cap
164.59B
PE Ratio
40.71
EPS
7.5605
Volume (Avg. Vol.)
2.65M
Day's Range
$305.55 - $313.63
52-Week Range
$251.10 - $339.04
Dividend & Yield
$9.13 (2.97%)
AMGN Stock Predictions, Articles, and Amgen News
Amgen, Inc. (AMGN) Offers Money-Back Guarantee to Heart Attack Victims on Repatha
Amgen (AMGN) is willing to offer a money-back guarantee to patients that suffer a heart attack while on its cardiovascular drug Repatha.
Amgen, Inc. (AMGN) Stock Crashed. Here’s How to Trade It.
Biotech stock Amgen (AMGN) is reeling Friday after disappointing heart study results. Here's how to capitalize on the pain in AMGN stock.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons
Amgen stock is back near all-time highs. Will its biosimilar portfolio power it higher, or will legal disputes hold the stock back?
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V)
Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V) all reported on their latest quarter Thursday. Here's how they performed.
Amgen, Inc. (AMGN) Q4 Earnings Preview
Amgen (AMGN) reports Q4 earnings on Thursday, and if something does weigh on AMGN stock, it'll likely be one of these three factors.
Amgen, Inc.: Capture Stronger Upside in AMGN Stock
Uncertainty, optimism and good liquidity are good reasons to consider an Amgen spread in lieu of AMGN stock in front of earnings.
Amgen, Inc. (AMGN) Stock Is a Bet on Fatter Yields
Amgen is a company with very fat margins and a growing dividend -- so you can buy AMGN stock today for tomorrow's yield.
Why the Amgen, Inc. (AMGN) Patent Case Is So Important
Amgen (AMGN) is pursuing a court case that will force the legal system to make a decision that will essentially become statute.
Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”
Pfizer (PFE) and Lockheed Martin (LMT) were among the stocks that were rattled Wednesday during Donald Trump's press conference.
Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons
AMGN stock has started 2017 with solid gains. But has Repatha gotten Amgen stock back on track, or will biotech weakness rear its head again?
SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!
Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon.
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gap Inc (GPS) and PriceSmart, Inc. (PSMT)
Amgen (AMGN) won a key patent dispute, Gap (GPS) posts strong holiday sales and PriceSmart (PSMT) profit rises ahead of Friday's trading.
3 Stocks to Watch on Wednesday: Tesla Motors Inc (TSLA), Agile Therapeutics Inc (AGRX) and Regeneron Pharmaceuticals Inc (REGN)
Tesla Motors (TSLA) dips on a vehicle deliveries miss, Agile Therapeutics (AGRX) tanks on trial results and Regeneron (REGN) suffers a legal defeat.
6 Dividend Stocks Increasing Payouts — AMGN CVS MCO FITB BXP CHH
Six notable dividend stocks raised their payouts last week, including Amgen (AMGN) and CVS Health (CVS). Here's what you need to know.
37 Biotechnology Stocks to Sell Now
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Big Stock Charts for Tuesday: Darden Restaurants, Inc. (DRI), Amgen, Inc. (AMGN) and Caterpillar Inc. (CAT)
Another round of buying pressure hits Caterpillar (CAT) and Darden Restaurants (DRI), but Amgen (AMGN) shares are slumping on a downgrade.
Amgen, Inc. (AMGN) Stock Might Be on Santa’s Buy List
Amgen (AMGN) just flashed a little encouragement to the bulls. While Amgen stock looks stuck, it very well could break out of its funk.
